Product Information

TRIAMCINOLONE ACET 400 MG/10 ML is a generic product labeled by Teva Parenteral Medicines, Inc., priced at $4.8690 per ML under NDC 00703024501. Its NADAC has been published 171 times since May 17, 2023.

FDA first approved this application on Oct 5, 2018. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

TRIAMCINOLONE ACET 400 MG/10 ML

Triamcinolone Acetonide
$4.8690per ML

Strength

40 mg/mL

NDC

00703024501

Classification

Generic

Dosage Form

INJECTION, SUSPENSION

Route

INTRA-ARTICULAR; INTRAMUSCULAR

Effective Date

8/19/2026

Active Ingredients

TRIAMCINOLONE ACETONIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA209852

FDA Approved

10/5/2018

TE Code

AB

On Market Since

8/29/2019

Pharmacological Classes

Corticosteroid Hormone Receptor Agonists
Corticosteroid

Price Statistics

The NADAC for TRIAMCINOLONE ACET 400 MG/10 ML has been published 171 times since May 17, 2023, and over the history we have for it it has risen 10.7%. The table below summarizes its recorded NADAC range and movement.

Current price$4.8690 per ML
All-time high$5.3839 (May 13, 2026)
All-time low$3.2942 (Feb 21, 2024)
52-week high$5.3839
52-week low$4.2675
Median price$4.1893
Average price$4.2247
Largest weekly change+27.6% (Nov 22, 2023)
Weeks tracked171
Tracking sinceMay 17, 2023

Price History

1W

-2.0%

1M

-2.0%

3M

-8.7%

6M

-9.1%

1Y

+14.1%

3Y

+33.9%

5Y

N/A

All

+10.7%

Generic Alternatives

The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 1% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of TRIAMCINOLONE ACET 400 MG/10 ML?

The current National Average Drug Acquisition Cost (NADAC) for TRIAMCINOLONE ACET 400 MG/10 ML, manufactured by Teva Parenteral Medicines, Inc., is $4.8690 per ML (NDC 00703024501), effective Aug 19, 2026.

How has the price of TRIAMCINOLONE ACET 400 MG/10 ML changed over time?

Over the history we have for it, the NADAC for TRIAMCINOLONE ACET 400 MG/10 ML has risen 10.7%. It has been tracked across 171 weekly CMS publications since May 17, 2023.

What are the highest and lowest recorded NADAC prices for TRIAMCINOLONE ACET 400 MG/10 ML?

Since May 17, 2023, the NADAC for TRIAMCINOLONE ACET 400 MG/10 ML has ranged from a low of $3.2942 (Feb 21, 2024) to a high of $5.3839 (May 13, 2026), with a median of $4.1893 per ML.

Are there cheaper alternatives to TRIAMCINOLONE ACET 400 MG/10 ML?

Yes. 5 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, TRIAMCINOLONE ACET 40 MG/ML VL, is $4.8380 per ML — about 1% below TRIAMCINOLONE ACET 400 MG/10 ML.

Who manufactures TRIAMCINOLONE ACET 400 MG/10 ML?

TRIAMCINOLONE ACET 400 MG/10 ML (NDC 00703024501) is labeled by Teva Parenteral Medicines, Inc., and CMS classifies it as a generic product.